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Cell proliferation is associated with a high rate of
aerobic glycolysis,which hasbeenwidely interpreted
as a compensatory mechanism for suppressed mito-
chondrial function, despite reports of high respiration
rates. The molecular mechanisms that link cell prolif-
eration with mitochondrial metabolism, dynamics,
and biogenesis remain obscure. Here, we show
that proliferation is associated with an increase in
both glycolysis and respiration, in conjunction with
mitochondrial fusion and biogenesis. Changes in
mitochondrialmorphologyandmass aredue to accu-
mulation of OPA1, MFN1, and TFAM, silencing any of
which hinders cell proliferation. Moreover, the levels
of OPA1,MFN1, and TFAM are regulated by the ubiq-
uitin ligaseAPC/CCDH1,which also controls proteaso-
mal degradation of key glycolytic, glutaminolytic, and
cell-cycle proteins. Thus, we have identified an
important component of the molecular mechanism
that coordinates cell proliferation with activation of
the mitochondrial metabolic machinery that provides
the necessary energy and biosynthetic substrates.
INTRODUCTION
Cell proliferation is an energetically demanding process that
requires enhanced metabolic activity to generate energy and
intermediates for de novo biosynthesis of the macromolecules
necessary to increase the cell mass. Eukaryotic cells generate
energy (ATP) by glycolysis in the cytosol and through oxidative
phosphorylation in the mitochondria. In most cell types the
majority of cellular ATP is generated by the mitochondria (Sar-
aste, 1999), and factors that compromise mitochondrial function
have been shown to inhibit proliferation (Van den Bogert et al.,
1988; DiGregorio et al., 2001). When mitochondrial function is
impaired (by hypoxia, pharmacological agents, and/or by
genetic means), glycolysis is enhanced to compensate for the
decreased mitochondrial ATP generation, leading to increased
accumulation of lactic acid, the principal by-product of glycol-
ysis. Thus, when high levels of lactate production have been
observed in proliferating cells, they have been interpreted as a
sign of suppressed mitochondrial function (Guppy et al., 1993;
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have shown that the mitochondria of proliferating cells are func-
tional, and that the increased lactate production in these cells
is not linked to mitochondrial dysfunction (Weinhouse, 1976;
Koppenol et al., 2011). Indeed, a significant increase in mito-
chondrial oxygen uptake has been observed during cell prolifer-
ation (Van den Bogert et al., 1988; Herzig et al., 2000; Schieke
et al., 2008). Because of these contradictory reports, the role
of mitochondria in cell proliferation remains controversial.
In addition to the generation of ATP, the mitochondria are also
vital sources of intermediates for de novo synthesis of the
macromolecules required to double the cell mass (Robbins
and Morrill, 1969; DeBerardinis et al., 2008; Vander Heiden
et al., 2009). These include essential steps in the synthesis of
fatty acid, heme, and pyrimidine nucleotides in the cytosol.
Factors that inhibit respiration suppress lipid, protein, and nucle-
otide synthesis and hinder cell proliferation (King and Attardi,
1989; Gattermann et al., 2004). Thus, it is reasonable to expect
that the mitochondrial function of proliferating cells should be
enhanced.
Mitochondrial function depends on mitochondrial mass,
morphology, ultrastructure, and coupling efficiency (Hacken-
brock et al., 1971; Arnoult et al., 2005; Chen et al., 2005; Gomes
et al., 2011). Cells arrested in G1 have been reported to have de-
fragmented mitochondria with reduced mass and function—a
state that is reversed when cells are stimulated to proliferate
(Neutzner and Youle, 2005). A strong link between cell prolifera-
tion and mitochondrial biogenesis has been reported in several
cell types (D’Souza et al., 2007; Lee et al., 2007, 2011; Cormio
et al., 2009), as has cell-cycle-dependent changes in mitochon-
drial morphology (Arakaki et al., 2006; Mitra et al., 2009).
Although the proteins that control mitochondrial biogenesis,
fusion, and fission have also been identified (Ekstrand et al.,
2004; Detmer and Chan, 2007), the mechanisms that coordinate
the expression level of these proteins with the cell cycle remain
largely unknown (Aguilar and Fajas, 2010).
The increased requirement for energy and metabolic interme-
diates during cell proliferation suggests that regulation of metab-
olism (both glycolytic and mitochondrial) must be linked to that
of the cell cycle. We have recently identified themolecular mech-
anism that leads to the increased utilization of glucose and
glutamine during cell proliferation. Accordingly, the abundance
of PFKFB3 (a key glycolytic regulator enzyme) andGLS1 (the first
and rate-limiting enzyme of glutaminolysis) is controlled by the
E3 ubiquitin ligase APC/CCDH1 (Almeida et al., 2010; Colombo
et al., 2010; Tudzarova et al., 2011). Thus, PFKFB3 and GLS1
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Aare released together with S phase cyclins at a nutrient-sensitive
critical point in G1 known as the restriction point, allowing for
coordination between cell-cycle progression into S phase and
the metabolism needed to underpin this phase. These results
prompted us to investigate whether the same mechanism may
control mitochondrial dynamics and biogenesis during cell prolif-
eration. We have used two types of primary murine cells—T cells
and embryonic fibroblasts (MEFs)—that can be stimulated to
proliferate by different mechanisms, to investigate whether pro-
liferation is accompanied by increased mitochondrial activity
and, if so, whether the mitochondrial proteins responsible for
this increase are under the control of APC/CCDH1.
RESULTS
Cell Proliferation Is Associated with Increased Rates
of Respiration and Aerobic Glycolysis
To investigate the relationship between cell proliferation, respira-
tion and aerobic glycolysis, we used murine spleen T cells and
MEFs that can be induced to proliferate by antigen stimulation
(anti-CD3 and anti-CD28 antibodies) or by serum refeeding,
respectively. Naive T cells freshly isolated from mouse spleen
are normally arrested in G0/G1 of the cell cycle (Figure 1A;
0 hr). Following antigen activation the cells began to proliferate,
so that by 72 hr the cells had divided several times (Figure 1B),
and the majority (53%) was in S phase (Figures 1A and 1C). The
rate of lactate production was initially low (0.01 mmol/hr/106 cells)
but increased 8- and 60-fold after 24 and 72 hr of activation,
respectively, coinciding with the entry of cells into S phase (Fig-
ure 1D). Proliferation was also accompanied by a dramatic
increase in the rate of both basal respiration and mitochondrial
ATP synthesis by oxidative phosphorylation (i.e., oligomycin-
sensitive respiration, Figures 1E and 1F). Uncoupling the mito-
chondria of these cells with an optimal concentration of carbonyl
cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP, 3 mM)
increased respiration from approximately 9 (0 hr) to 51 pmol
O2/s/10
6 cells after 72 hr of activation (data not shown), indi-
cating a significant increase in the respiratory capacity (mito-
chondrial mass). The linear correlation between the percentage
of cells in S phase, lactate production and respiration rates
(Figure 1G) shows that cell proliferation is correlated with cellular
energetic metabolism, both glycolytic and mitochondrial. We
have also purified CD4+ and CD8+ T cells separately and inves-
tigated cell proliferation, glycolysis, and respiration after anti-
genic stimulation. We observed that the correlation between
metabolism and proliferation is highly maintained and resembles
that of the entire T cell population (see Tables S1A and S1B avail-
able online).
In normally proliferating MEFs, 55%–60% cells were in
S phase, 30%–35% in G1, and 5%–10% in G2/M (72 hr, Fig-
ure S1A). Serum starvation for 72 hr resulted in the accumulation
of cells in G1 (74%) with 19% in S phase (0 hr, Figure S1A).
Within 24 hr of serum refeeding, proliferation was restored so
that 59% of cells had reentered S phase; further incubation for
48 hr did not significantly change the cell-cycle profile (Fig-
ure S1A). Changes in lactate production and respiration were
consistent with progression of the cell cycle (Figures S1B–
S1D). After 72 hr of serum starvation, the rate of lactate produc-
tion dropped dramatically (0 hr, Figure S1B), and both the basal
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declined significantly from those of proliferating MEFs prior to
serum starvation (72 hr). Within 24 hr of serum refeeding, there
was a significant increase in the rate of lactate production and
in the basal and oligomycin-sensitive respiration rates (Figures
S1B and S1C). The FCCP-uncoupled maximum respiration of
proliferating MEFs was 189 pmol O2/s/10
6 cells (data not
shown). After 72 hr serum starvation (0 hr), this value declined
to 118 and increased back to 195 pmol O2/s/10
6 cells after
24 hr serum refeeding (data not shown), further demonstrating
that respiratory capacity matches the proliferative state of
the cell.
Cell Proliferation Is Associated with Mitochondrial
Biogenesis
The increased respiration rates of proliferating cells suggested
that they might have more active mitochondria, more mitochon-
drial mass, or both. Thus, we monitored the changes in mito-
chondrial mass after stimulating naive T cells and MEFs to
proliferate. We performed a multiparameter analysis, measuring
the amount of mitochondrial DNA in the cells (mtDNA copy
number), the mitochondrial matrix volume (citrate synthase
[CS] enzymatic activity), the expression level of themitochondrial
transcription factor (TFAM) and of a representative mitochon-
drial protein (Cox-iv) by western blotting, and by labeling of
themitochondria withMitoTracker Green FM fluorescence. Non-
proliferating (naive) T cells had 55 ± 7.3 mtDNA copies per cell,
which increased to 170 ± 13 within 72 hr of stimulation (Fig-
ure 2A). A similar trend was observed in pure CD4+ and CD8+
T cells (Tables S1A and S1B). Serum-starved MEFs had 188 ±
14 mtDNA copies per cell, which increased to 304 ± 39 within
24 hr of serum refeeding (Figure S2A), attaining a level similar
to that before starvation (315 ± 27 copies per cell). CS enzymatic
activity and expression of TFAM and Cox-iv also increased as
proliferation progressed in both T cells (Figures 2B and 2C)
and MEFs (Figures S2B and S2C). The amount of MitoTracker
Green FM accumulated by mitochondria, and consequently its
fluorescence intensity, is known to be determined by the mito-
chondrial mass. Stimulation of T cells to proliferate resulted in
an increase in the amount of MitoTracker Green FM accumula-
tion, as shown by both flow cytometry and confocal microscopy
(Figures 2D and 2E). The median ± SD MitoTracker Green FM
fluorescence intensity (assessed by flow cytometry) following
stimulation of these cells to proliferate was 65 ± 9 a.u. (0 hr),
83 ± 7 a.u. (24 hr), 350 ± 25 a.u. (48 hr), and 490 ± 33 a.u.
(72 hr). In serum-starved MEFs the median fluorescence of Mito-
Tracker Green FM was approximately 295 ± 21 a.u. This
increased to approximately 720 ± 59 a.u. after 24 hr serum re-
feeding, achieving a level similar to that before serum starvation
(Figure S2D). These results indicate that cell proliferation is asso-
ciated with mitochondrial biogenesis.
Cell Proliferation Is Associated with a Change in
Mitochondrial Morphology
We then investigated mitochondrial morphology using confocal
microscopy of MEFs stained with MitoTracker Green FM and
Hoechst 33342. It was not possible to carry out this type of
experiment in T cells because they are too small (especially the
nonactivated ones) for detailed mitochondrial morphology
CT
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Figure 1. Respiration and Aerobic Glycolysis Are Simultaneously Upregulated during T Cell Proliferation
(A–G) Murine T cells were activated by culture in plates coated with 5 mg/ml anti-CD3 and 5 mg/ml anti-CD28 antibodies. Representative flow cytometry plots of
cell-cycle profile (A) and cell proliferation (B) are demonstrated by CFSE fluorescence. The cell-cycle profile of T cells at different times after activation as
determined by BrdU incorporation and total DNA content (C). Percentage of cells in S phase and rate of lactate production are shown in (D) Also shown:
Representative respirometry plot of nonactivated and 72 hr activated T cells (E), basal and oligomycin-sensitive respiration rates (F), and correlation between
basal respiration rate, lactate production rate and percentage of cells in S phase (G). Values in (C) and (G) are mean of n = 3–5. Values in (D) and (F) are mean ± SD
(n = 3–5). See also Figure S1 and Table S1.
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Danalysis. Imaging was carried out every hour for the first 3 hr after
serum refeeding, and every 3 hr thereafter (Figures 3A and 3B).
We observed that proliferating MEFs (72 hr) have a highly
interconnected tubular mitochondrial network. Following serum
starvation (0 hr), the tubular network was completely lost,468 Cell Metabolism 15, 466–479, April 4, 2012 ª2012 Elsevier Inc.and mitochondria acquired a highly fragmented punctate
structure. During serum starvation there was no reduction in
cell viability (R98%, as determined by trypan blue exclusion;
data not shown), ruling out the possibility that the observed
change is caused by cell death. Within 2 hr of serum refeeding,
BA
DC
24h
Cox-iv
α-tubulin
24 hr 72 hr0 hr 48 hr
1.0 1.8 4.3 4.9
1.0 2.5 4.5 4.7
E
72hr
rh42rh0
48hr
10 µm 10 µm
10 µm 10 µm
TFAM
0 24 48 72
0
5
10
15
20
25
C
S
 a
ct
iv
ity
 [U
/1
06
 c
el
ls
]
Time [hr]
*
**
*
0 24 48 72
0
50
100
150
200
m
tD
N
A
 c
op
y 
nu
m
be
r p
er
 c
el
l
Time [hr]
*
**
*
0
27
55
83
111
100 101 102 103 104
MitoTracker Green fluorescence
C
el
l c
ou
nt
s
r
r
r
r
Figure 2. T Cell Proliferation Is Associated with Mitochondrial Biogenesis
(A–E) Murine T cells were activated, and samples were taken at intervals of 24 hr to determine (A) mtDNA copy number by quantitative PCR with primers against
the mtDNA-encoded gene (Nd5) and a single-copy nuclear gene (Sdha), (B) CS enzymatic activity in total cell lysate by spectrophotometry, (C) the level of
expression of the mitochondrial transcription factor (TFAM) and a mitochondrial protein (cytochrome c oxidase subunit-iv, Cox-iv) by western blot, (D) mito-
chondrial mass by flow cytometry after staining live cells with 100 nM MitoTracker Green FM, and (E) live-cell imaging of the mitochondrial mass using laser-
scanning confocal microscopy after staining with 100 nM MitoTracker Green FM and Hoechst 33342. Values in (A) and (B) are mean ± SD of n = 3–5. (C) shows
a representative western blot with densitometry values of n = 3, (D) shows representative flow cytometry traces, and (E) shows representative images of n = 3–5.
*p% 0.05; **p% 0.01, ANOVA. See also Figure S2.
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Dthe mitochondria started to fuse and to form the tubular network
morphology. This was paralleled by significant increases in
respiration, lactate production rate, and percentage of cells in
S phase (Figures 3C–3E). However, the first significant change
in mtDNA copy number was not observed until 6 hr after serum
refeeding (Figure 3F) andwas accompanied by a further increase
in the basal and FCCP-uncoupled maximum respiration (Figures
3C, 3F, and 3G), indicating an enhanced respiratory capacity
(mitochondrial mass).CCell Proliferation Is Associated with Upregulation
of Mitochondrial Fusion and Biogenesis Proteins
We investigated whether the observed changes in mitochondrial
morphology in proliferating or G0/G1-arrested MEFs are caused
by alterations in the expression levels of proteins involved in
mitochondrial fusion (such as OPA1 and MFN1), or in mitochon-
drial fission (such as DRP1 and p-DRP1). We also evaluated
whether the increase in mitochondrial mass during cell prolifera-
tion correlates with the expression level of TFAM, the mtDNAell Metabolism 15, 466–479, April 4, 2012 ª2012 Elsevier Inc. 469
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Figure 3. Changes in Mitochondrial Morphology and Metabolic Activity in MEFs during Cell Proliferation
(A–G) MEFs were grown to subconfluence and accumulated in G0/G1 by serum starvation for 72 hr. Cells were then refed with serum. Mitochondrial morphology
was evaluated at indicated time points using live-cell confocal microscopy after staining with 100 nM MitoTracker Green FM and Hoechst 33342 (A). The
proportion of cells that display fragmented, tubular, or intermediate mitochondrial morphology was visually scored (B, 200 cells for each time point). Basal and
oligomycin-sensitive respiration (C), rate of lactate production and percentage of cells in S phase (D), cell-cycle profile (E), mtDNA copy number (F), and FCCP-
uncoupled maximum respiration (G) were assessed at the indicated time points. Pictures in (A) show representative images of three independent experiments;
(B), (C), and (E) show mean of n = 3; and (D), (F), and (G) show mean ± SD (n = 3–5). *p% 0.05, **p% 0.01, significant difference from previous time point (paired
sample t test).
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Dtranscription and replication factor that controls mitochondrial
biogenesis. In addition we correlated the expression level of
these mitochondrial proteins with that of CDH1, an adaptor
protein crucial for the activity of the APC/CCDH1 complex that
controls cell-cycle progression from G1 to S. The entry of cells
into S phase, the change in mitochondrial morphology from470 Cell Metabolism 15, 466–479, April 4, 2012 ª2012 Elsevier Inc.punctate to a tubular network, and the increase in mitochondrial
mass (mtDNA copy number) following serum refeeding were
associated with significant changes in the amount of Cdh1,
Opa1, Mfn1, and Tfam gene and protein expression, as as-
sessed by quantitative real-time PCR and western blotting
(Figures 4A–4C and S4A). Expression of Opa1, Mfn1, and Tfam
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AmRNA and protein was low in serum-starved cells (0 hr), which
are G0/G1 arrested, and increased significantly within 2 hr of
serum refeeding, reaching the preserum-starvation state by
9 hr. This coincided with a significant reduction in the amount
of Cdh1 mRNA and protein (Figures 4A–4C). In contrast the
mRNA and protein levels of Drp1 and p-DRP1 remained
constant, indicating that the observed change in mitochondrial
morphology from punctate to tubular during the transition from
G1 to S phase of the cell cycle was due to increased fusion,
rather than reduced fission. To confirm that DRP1 does not
play a role in serum-induced transition from G1 to S phase, we
silenced this gene with small interfering RNA (siRNA) and evalu-
ated the cell-cycle profile, the change in cell number, and the
cellular ATP content (Figures S3A–S3E). Drp1 silencing affected
the proliferating control cells, most probably due to its role in
mitosis. Thus, we synchronized MEFs at G2/M by treatment for
14 hr with 40 ng/ml nocodazole and released them into fresh
medium without the drug. Both DRP1 and p-DRP1 protein levels
were high during G2/M, significantly declined as cells entered
G1, and did not change further as cells moved to S phase
(Figures S3F and S3G), further supporting our observation that
the change in mitochondrial morphology at G1 to S transition
is due to accumulation of the mitochondrial fusion proteins
OPA1 and MFN1, rather than to changes in mitochondrial fission
proteins.
OPA1, MFN1, and TFAM Are Substrates
of APC/CCDH1-Mediated Proteasomal Degradation
The inverse correlation between the protein level of CDH1 and
those of OPA1, MFN1, and TFAM during G1 and S phase
suggested the possible involvement of APC/CCDH1 in the protea-
somal degradation of OPA1, MFN1, and TFAM. Because the
presence of KEN and/or D box recognition motifs in target pro-
teins is necessary for proteasomal degradation by APC/CCDH1,
we scanned the protein sequences of OPA1, MFN1, and TFAM
using an online bioinformatic tool (http://www.elm.eu.org), and
found that MFN1 and TFAM each have a D box motif, whereas
OPA1 has both KEN and D box motifs (Figures 4D and S4C).
We have also scanned the protein sequence of other mitochon-
drial fusion and biogenesis proteins for the presence of these
recognition motifs and found that most of them have KEN and/
or D box, conserved at least in human and mouse (Table S2).
Silencing of Cdh1 by siRNA in G0/G1-arrested cells resulted in
a significant increase in the protein level of OPA1 and TFAM
but had no significant effect on the expression level of DRP1 or
Cox-iv (data not shown), a mitochondrial protein that has no
KEN or D box (Figure 4E). Transfection of asynchronously prolif-
erating MEFs with Yfp-Cdh1 dramatically reduced the amount
of both endogenous and cotransfected OPA1, MFN1, and
TFAM proteins (Figures 4F and S4B). Further evidence that
OPA1, MFN1, and TFAM are recognized by APC/CCDH1 using
their KEN and D box was obtained using site-directed mutagen-
esis experiments in which the CDH1-targeting amino acid
sequences were mutated to alanine (Figures 4D and S4C). Co-
transfection of Yfp-Cdh1 with WT Opa1,Mfn1, or Tfam reduced
the expression of these proteins to a level below that of untrans-
fected controls (Figures 4G and S4B). The KEN or D box single
mutants of OPA1 were partially stabilized, whereas the double-
mutant OPA1 and D box mutants of MFN1 and TFAM were
RE
TRCcompletely stabilized, even when overexpressed with YFP-
CDH1.
These results demonstrate that proteasomal degradation of
OPA1, MFN1, and TFAM controls the changes in mitochondrial
morphology and mass observed during G0/G1 arrest and prolif-
eration. Indeed, treatment of serum-starved MEFs with 10 mM
MG132 (a general proteasomal inhibitor) prevented endogenous
OPA1, MFN1, and TFAM protein degradation (Figure 5A)—re-
sulting in the accumulation of ubiquitinated proteins, as detected
by immunoprecipitation (Figures 5B and S4D)—and restored the
tubular mitochondrial network (Figure 5C). In cells overexpress-
ing YFP-CDH1, inhibition of the proteasome byMG132 was able
to completely stabilize WT, KEN, or D box single-mutant OPA1
and WT TFAM, whereas it had no additional effect on the stabi-
lization of double-mutant OPA1 or D box mutant TFAM (Figures
5D and 5E). Furthermore, co-overexpression of double-mutant
OPA1 and D box mutant MFN1 restored the network mitochon-
drial morphology in serum-starved MEFs (Figure 5F). This further
confirms that the KEN and D boxes of OPA1, MFN1, and TFAM
are essential for the APC/CCDH1-mediated proteasomal degra-
dation of these proteins.
Silencing of OPA1 or TFAM Hinders Cell Proliferation
To evaluate the role played by OPA1 and TFAM in cell-cycle
progression from G1 to S phase and in cell proliferation, MEFs
were transfected with Opa1 or Tfam siRNA for 72 hr under
both proliferating and serum-starved conditions. To maintain
the complete silencing of Opa1 or Tfam during serum refeeding,
MEFs were transfected with siRNA again at the time of serum
addition. Efficiency of the silencing was assessed by quantitative
real-time PCR and western blot analysis (Figures 6A–6C).
Silencing of either Tfam or Opa1 resulted in a significant reduc-
tion in mtDNA copy number in all conditions; however, this effect
was more pronounced in Tfam-silenced cells (Figure 6D).
Silencing Opa1 or Tfam had no significant additional effect on
the percentage of cells in S phase during the 72 hr serum-starva-
tion period. However, silencing either of these proteins dramati-
cally reduced the percentage of cells in S phase and the increase
in cell number in proliferating controls and following serum re-
feeding (Figures 6E and 6F). In contrast, silencing of Drp1 had
no effect on the percentage of cells that entered S phase, or
on the increase in cell number during the 24 hr period following
serum refeeding (Figure S3D). However, Drp1 silencing may
slow down proliferation in the long term (when a cell undergoes
several cell division cycles) by interfering with mitosis, as seen
from the accumulation of more cells in mitosis and the reduction
in cell number (Figures S3C and S3D, proliferating control). Both
Opa1- and Tfam-silenced cells had a significantly higher rate
of lactate production in all conditions (Figure 6G), indicating
that in this situation glycolysis is upregulated to maintain cellular
ATP, which is sensitive to the replacement of glucose with
galactose in the medium (Figure 6H). Indeed, in Opa1- and
Tfam-silenced cells, respiration rates (both basal and FCCP
uncoupled) were significantly lower (Figure 7A). Silencing of
Opa1 in proliferating cells induced defragmentation of the mito-
chondrial network, whereas Tfam silencing had no significant
effect (Figures 7B and 7C). In serum-starved cells, Opa1 or
Tfam silencing had no increased effect on the already defrag-
mented mitochondrial morphology (Figures 7B and 7C).
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Figure 4. Mitochondrial Fusion and Biogenesis Proteins OPA1 and TFAM Are Targeted for CDH1-Dependent Proteasomal Degradation
in G0/G1-Arrested Cells
(A–G) MEFs were refed with serum after 72 hr serum starvation. The mRNA (A) and protein levels (B) of Cdh1, Opa1, p-DRP1, Drp1, and Tfam were evaluated by
quantitative real-time PCR and western blot, respectively. (C) Densitometry values of three independent western blots are shown. (D) Consensus KEN and D box
motifs in the protein sequence of OPA1 and D box motif in that of TFAM, and the mutants generated by site-directed mutagenesis. (E) siRNA-mediated silencing
ofCdh1 in MEFs leads to an increase in the protein levels of OPA1 and TFAM, but not DRP1. *p% 0.05, **p% 0.01 versus control and scrambled siRNA (ANOVA).
(F) Overexpression of Opa1 (upper panel) and Tfam (lower panel) in proliferating MEFs in the presence or absence of overexpressed Yfp-Cdh1; CDH1 (endog),
endogenousCDH1protein; EV, cells transfectedwith empty vector; control, nontransfected cells. Numerical values at the bottom of upper and lower panels show
mean densitometry values of OPA1 and TFAM, respectively (n = 3). **p% 0.01 significantly different from each other (ANOVA). (G)Mutations of the KEN andD box
motifs stabilize OPA1 and TFAMproteins. Plasmids carryingWT ormutant sequence ofOpa1 (left panel) and Tfam (right panel) were cotransfected with Yfp-Cdh1
for 48 hr. Control, nontransfected cells. Numerical values at the bottom of the panels are mean densitometry values of OPA1 (left panel) and TFAM (right panel)
(n = 3). *p% 0.05, **p% 0.01 paired sample t test. (A), (C), and (E, right panel), showmean ± SD (n = 3–5); (B), (E, left panel), (F), and (G) show representative blots of
three independent experiments. See also Table S2 and Figure S3.
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CT
EDHowever, after 24 hr of serum refeeding, the mitochondria of
Opa1-silenced cells remained defragmented, whereas a tubular
mitochondrial network was present in Tfam-silenced cells. We472 Cell Metabolism 15, 466–479, April 4, 2012 ª2012 Elsevier Inc.have also overexpressed Cdh1 in T cells and MEFs and
observed that it significantly reduces cell proliferation, mitochon-
drial biogenesis and function, and leads to mitochondrial
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Afragmentation (Figure S5). These results suggest that both mito-
chondrial fusion and biogenesis are essential for cell proliferation
and are under the control of APC/CCDH1.
We also investigatedmitochondrial function in various prolifer-
ative cells lines (normal and cancer cells) and studied the effect
of mitochondrial inhibitors on cell proliferation (Table S4). We
observed that functioning mitochondria are essential for cell
proliferation and that inhibition of mitochondrial function abro-
gates proliferation.
DISCUSSION
Cell proliferation is a process that requires macromolecular
synthesis and entails considerable enhancement of metabolic
reactions. Energy, in the form of ATP, and intermediates for
macromolecular synthesis are generated by glycolysis in the
cytosol and by respiration in the mitochondria. Proliferating
cells are known to have a high rate of glycolysis, and this
is often interpreted as a compensatory mechanism for sup-
pressed mitochondrial function (Guppy et al., 1993; Brand
andHermfisse, 1997; Bauer et al., 2004). The notion ofmitochon-
drial dysfunction in proliferating cells is counterintuitive with
the need to generate energy and substrates. Thus, the role
played by the mitochondria in cell proliferation has remained
controversial.
Our results show that the basal levels of glycolysis and respira-
tion in nonproliferating cells can be dramatically increased when
cells are stimulated to proliferate. Moreover, in both cell types we
studied (T cells and MEFs), the increase in glycolysis is greater
than that of respiration. However, this is not likely to be due to
glycolysis becoming the main source of energy in proliferating
cells because the amount of ATP generated by just a 2-fold
increase in respiration can be achieved only when glycolysis
is increased by at least 13-fold. The high rate of glycolysis
observed in proliferative cells is more likely to be part of a
concerted increase in mechanisms of both energy and interme-
diate production, rather than a compensation for suppressed
mitochondrial function. Indeed, evidence for the vital role ofmito-
chondria in cell proliferation comes from our experiments in
which genetic or pharmacological agents that interferewithmito-
chondrial function significantly enhance glycolysis, but suppress
cell proliferation, in agreement with previous reports (King and
Attardi, 1989; Gattermann et al., 2004). Our data show that, in
the absence of mitochondrial function, glycolysis alone cannot
support cell proliferation despite producing high amounts of
ATP. A likely explanation for this is that glycolysis cannot provide
all themetabolic intermediates for the synthesis of lipids, nucleo-
tides, and heme that normally takes place during cell division.
We also demonstrated that the high rate of respiration
observed during cell proliferation is associated with a change
inmitochondrial morphology from punctate (in G1-arrested cells)
to a tubular network, and with an increase in mitochondrial
mass through formation of new mitochondria (mitochondrial
biogenesis). Defragmentation of the mitochondrial network in
G1-arrested cells has been reported in yeast; this was shown
to be associated with a reduction in the level of themitochondrial
fusion protein Fzo1, an ortholog of the mammalian MFN1 (Neu-
tzner and Youle, 2005). The reduction in the level of Fzo1 was
demonstrated to be due to ubiquitination-mediated proteasomal
RE
TRCdegradation, although the detailed molecular mechanism was
not investigated. Mitochondrial network defragmentation has
also been observed in mammalian cells during mitosis, and
this was demonstrated to be due to increased expression and
activity of the mitochondrial fission protein DRP1 (Arakaki
et al., 2006; Taguchi et al., 2007; Horn et al., 2011; Kashatus
et al., 2011). It was also shown that the level of DRP1 dramati-
cally drops as cells exit mitosis, due to APC/CCDH1-mediated
proteasomal degradation (Horn et al., 2011). Although the pro-
teasomal degradation of DRP1 upon transition from mitosis to
G1 may account for the low level of DRP1 during G1, it cannot
explain the defragmentation of mitochondria in G1-arrested cells
and the formation of the tubular network upon entry into S phase.
If mitochondrial morphology during the transition from G1 to S
phase of the cell cycle were controlled by the APC/CCDH1-medi-
ated regulation of DRP1 protein level, one would expect a high
level of expression of DRP1, as well as defragmented mitochon-
dria, upon G1 to S transition and in S phase when APC/CCDH1
activity disappears. However, previous reports from various
groups (Neutzner and Youle, 2005; Mitra et al., 2009) show the
opposite. This is in agreement with our observation that serum
refeeding of G1-arrested cells leads to the formation of the mito-
chondrial network by increasing mitochondrial fusion proteins
(OPA1 and MFN1) without a change in the level of DRP1, as
has also been reported for yeast (Neutzner and Youle, 2005).
Thus, our data demonstrate that mitochondrial fragmentation
in G0/G1-arrested cells is due to suppression of fusion, whereas
the fragmentation observed in mitosis (Horn et al., 2011; Kasha-
tus et al., 2011) is due to enhanced fission.
By using a time course analysis of cell proliferation, respira-
tion, mitochondrial morphology, and biogenesis, following
serum refeeding of G1-arrested MEFs, we showed that the initial
increase in respiration coincides with the formation of the tubular
mitochondrial network and precedes any detectable increase in
mitochondrial mass. In Opa1-silenced cells, in which formation
of the tubular mitochondrial network was abolished, there was
no such increase in respiration, and cell proliferation was
blocked. Mitochondria with tubular network morphology are
known to be energetically more efficient than defragmented
ones (Gomes et al., 2011), and the formation of tubules has
been shown to be a prerequisite for G1 to S transition (Mitra
et al., 2009). Thus, the change in mitochondrial morphology we
observed immediately after serum refeeding represents a rapid
adaptation of cells in order to generate more energy using the
mitochondrial mass already available. Nevertheless, formation
of the mitochondrial network alone, in the absence of mitochon-
drial biogenesis, is not sufficient to enable cells to proliferate
because TFAM-silenced cells did not progress into S phase,
despite the appearance of the tubular mitochondrial morphology
following serum refeeding. Indeed, the increase in mitochondrial
oxygen uptake during cell proliferation has been shown to peak
during S phase (Robbins and Morrill, 1969), at which time we
have shown that there is an increase in the mitochondrial mass
following earlier formation of the tubular network.
In Tfam-silenced cells there was a significant reduction in
mitochondrial mass despite the presence of a tubular mitochon-
drial network. In contrast, silencing Opa1 prevented both the
formation of the tubular network and the increase in mtDNA
copy number upon serum refeeding, supporting the observation
CT
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Figure 5. Inhibition of the Proteasome Prevents OPA1 and TFAM Protein Degradation during Cell-Cycle Arrest
(A–F) MEFs were serum starved for 72 hr and treated with 10 mMMG132 for 2 hr, where indicated. Shown in (A) are representative western blot and densitometry
values showing the expression level of CDH1, OPA1, and TFAM proteins. OPA1 and TFAM proteins were immunoprecipitated (IP) with anti-OPA1 and anti-TFAM
antibodies conjugated to protein G-Dynabeads (Invitrogen), and immunodetection was carried out using anti-ubiquitin antibody (B). Representative images of
mitochondrial morphology analyzed by confocal microscopy after staining with 100 nM MitoTracker Green FM and Hoechst 33342 are shown in (C); right graph
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Athat mitochondrial fusion may play a role in the maintenance of
mtDNA copy number (Chen et al., 2010). In both Opa1- and
Tfam-silenced cells, we observed a dramatic reduction in the
percentage of cells in S phase, despite a significant enhance-
ment of glycolysis, indicating that glycolysis alone cannot
support cell proliferation when mitochondrial function, fusion,
and/or biogenesis are hindered.
Mitochondrial biogenesis has been widely reported to be
a common feature of proliferative cells (Cormio et al., 2009;
D’Souza et al., 2007; Lee et al., 2007, 2011). It is known thatmito-
genic stimuli lead to mitochondrial biogenesis by the induction
of signaling pathways and transcriptional activation of mitochon-
drial genes (Herzig et al., 2000; Li et al., 2005). However, the role
played by posttranslational protein control in mitochondria
biogenesis is largely unknown. Because posttranslational modi-
fications are essential for the control of cell-cycle regulator
proteins, we reasoned that the same mechanisms may also
operate on mitochondrial fusion- and biogenesis-related
proteins to coordinate cell-cycle progression with the provision
of the required energy and metabolic intermediates.
Indeed, our results show that in serum-starved cells the mito-
chondrial fusion proteins OPA1 andMFN1 and themitochondrial
biogenesis protein TFAM are targeted for proteasomal degrada-
tion by APC/CCDH1, the E3 ubiquitin ligase that is known to
induce proteasomal degradation of cell-cycle proteins and of
at least two very important metabolic enzymes, PFKFB3 and
GLS1 (Almeida et al., 2010; Colombo et al., 2010; Tudzarova
et al., 2011), during mitosis and G1 phase of the cell cycle. The
proteasomal degradation of OPA1, MFN1, and TFAM results in
the formation of punctate mitochondrial morphology and a
reduction in mitochondrial mass and function, concomitant
with a reduction in the overall cellular metabolic rate and arrest
of the cells in G1. Upon serum refeeding the expression level
of CDH1 declines significantly, leading to the accumulation of
OPA1, MFN1, and TFAM proteins and the subsequent formation
of a mitochondrial network and mitochondrial biogenesis. Our
data show that OPA1 is targeted for proteasomal degradation
using the well-known CDH1 recognition KEN- and D box motifs.
Site-directed mutagenesis of either of these motifs stabilizes
the protein only partially; however, mutagenesis of both sites
stabilizes the protein completely, despite the abundance of
CDH1. In contrast, TFAM and MFN1 are recognized via a D
box, and mutagenesis of this site stabilizes the proteins com-
pletely. Further evidence that CDH1 facilitates the proteasomal
degradation of OPA1, MFN1, and TFAM was obtained from
siRNA-mediated silencing of Cdh1 that led to a significant
increase in these proteins. In addition to OPA1, MFN1, and
TFAM, other mitochondrial regulator proteins (e.g., PGC-1a,
NRF1, NRF2, PolG, POLRMT) have KEN- and/or D box motifs,
reinforcing the idea that these mitochondrial processes are
controlled by the proteasome.
RE
TRshows quantification performed as in Figure 3B. Representative western blots and
WT or D box and/or KEN box mutant Opa1 (D) and WT or D box mutant Tfam (E)
the 48 hr incubation period before lysing cells for western blotting. MEFs were cotr
the 72 hr serum starvation (F), and mitochondrial morphology was evaluated as in
are shown. (A), (D), and (E, right panels) showmean ± SD densitometry values (n =
See also Figure S4.
CIn summary our results show that the activity of the E3 ubiqui-
tin ligase APC/CCDH1 coordinates cell-cycle progression and the
machinery that provides energy and biosynthetic substrates
required for cell growth and division. These results, together
with our previous demonstration of the regulation of glycolysis
and glutaminolysis by APC/CCDH1, will help to clarify further the
relationship between cell-cycle progression and the harnessing
of the metabolic requirements necessary for its successful
accomplishment.EXPERIMENTAL PROCEDURES
Cell Culture, Treatments, and Transfection
Isolation and Cultivation of Mouse Spleen T Cells
Naive T cells (CD4+, CD8+, and CD4+ plus CD8+) were isolated from spleens
of 6- to 8-week-old male C57BL/6 mice using Dynal Mouse T Cell Negative
Isolation Kits. The Dynabeads were rinsed five to six times with copious
amounts of Dulbecco’s PBS (DPBS) to remove the preservative (NaN3), and
the antibody cocktail was dialyzed for 36 hr against DPBS at 4C using
Slide-A-Lyzer Dialysis Cassette, 10K MWCO (Thermo Scientific). The purity
of T cell preparations (R98%) was determined by flow cytometry after staining
with FITC-conjugated anti-CD4 and anti-CD8 (BioLegend) and anti-CD3 anti-
bodies (Abcam). Isolated naive T cells were resuspended in RPMI-1640
medium at 13 106 cells/ml and allowed to recover overnight before activation.
For activation, 23 106 cells/well were seeded in 6-well plates coated overnight
with 5 mg/ml anti-CD3 and 5 mg/ml anti-CD28 functional grade antibodies
(eBioscience) in bicarbonate buffer. The CD8+ cells were supplemented with
20 ng/ml (110 IU/ml) mouse recombinant IL-2 (Invitrogen) (Lai et al., 2009).
Nonactivated control cells were seeded in plates without antibody coating.
All T cell cultures and experiments were performed with RPMI-1640 medium
supplemented with 10% dialyzed FCS, 100 U/ml penicillin, 100 mg/ml strepto-
mycin, 4 mM L-glutamine, 50 mM b-mercaptoethanol, 25 mM HEPES, 1 mM
sodium pyruvate and 0.1 mM nonessential amino acids. To assess prolifera-
tion, nonactivated T cells were stained with 10 mMcarboxyfluorescein succini-
midyl ester (CFSE; Invitrogen) and activated as above. Sampleswere collected
at regular intervals, fixed with 3.7% formaldehyde, and used for analysis of cell
proliferation by flow cytometry.
MEF Culture and Serum Starvation
MEFs isolated from C57BL/6 mice (a kind gift from Dr. Adolfo Saiardi, CBU
MRC LMCB, London) were maintained in high-glucose DMEM supplemented
with 10% FCS, 4 mM L-glutamine, 1 mM pyruvate, 100 U/ml penicillin, and
100 mg/ml streptomycin in a 5% CO2 incubator. To avoid the decline in cell
proliferation due to replicative senescence, only early passages (up to p15)
ofMEFswere used in our experiments. For serum-starvation experiments cells
were seeded at 0.015 3 106 cells/cm2 in medium containing 10% FCS and
incubated for 24 hr to reach approximately 80% confluence. Cells were then
rinsed three times with copious amounts of Hank’s balanced salt solution
(HBSS), containing Ca2+ and Mg2+, to remove the serum, and incubated for
72 hr with serum-starvation medium (DMEM with 0.1% FCS). During serum
starvation, samples were collected at the time points indicated. Following
starvation, cells were refed with 10% FCS medium and incubated for
24–48 hr as indicated.
Transfections with siRNA and plasmid DNAwere carried out using jetPRIME
transfection reagent (Polyplus-transfection), according to the manufacturer’s
recommendation. Transfection efficiency, evaluated by flow cytometry, of
control Alexa Fluor 555-siRNA (QIAGEN)- and pEGFP-N1 plasmid DNA-trans-
fected cells wasR95% and approximately 80%, respectively.
C
EDdensitometry analysis of proliferating MEFs cotransfected with Yfp-Cdh1 and
for 48 hr are shown; a total of 10 mM MG132 was added for 2 hr at the end of
ansfected with the KEN and D boxmutantOpa1 and D boxmutantMfn1 during
Figure 3B. Representative confocal images of three independent experiments
3). *p% 0.05, **p% 0.01 ANOVA for (A), and paired sample t test for (D) and (E).
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Figure 6. siRNA-Mediated Silencing of Opa1 or Tfam Interferes with Cell Proliferation
(A–H) Silencing of Opa1 or Tfam was carried out for 72 hr either under proliferating (10% FCS) or serum-starved (0.1% FCS) conditions. Opa1 and Tfam protein
expression (A) and mRNA levels (B and C) were evaluated by western blotting and quantitative real-time PCR, respectively. The mtDNA copy number was
determined by quantitative PCR (D), and cell-cycle profile was determined by BrdU incorporation (E). Cells were counted at each time point to determine the
change in cell number relative to the number at the beginning of serum starvation (F). Lactate was determined using a lactate kit (G), and cellular ATP was
determined in proliferating cells and in cells supplied with serum for 24 hr following 72 hr serum starvation (H). (A) shows representative blots with mean
densitometry values (n = 3) at the top of each band, (B)–(D) and (F)–(H) show mean ± SD of n = 3, and (E) shows mean of n = 3 independent experiments. Control,
nontransfected cells. *p% 0.05, **p % 0.01 versus control and scrambled siRNA transfected cells (ANOVA, Tukey’s post hoc test); #p% 0.05, Opa1- versus
Tfam-siRNA transfected cells. See also Table S4.
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DCell-Cycle Analysis and Lactate Determination
Cells were incubated with 10 mM BrdU for 1 hr by taking supernatants for
lactate determination at the beginning and end of the 1 hr incubation. The
BrdU-labeled cells were collected and cell number was determined, for the
normalization of lactate production rate. Cells were spun down, fixed, and
further processed according to the APC BrdU Flow Kit protocol, and total476 Cell Metabolism 15, 466–479, April 4, 2012 ª2012 Elsevier Inc.cellular DNA was stained with 7-aminoactinomycin D (7-AAD). The proportion
of cells in S phase (BrdU-positive cells) and total cellular DNA content was
determined by flow cytometry (CyAn ADP flow cytometer; DAKO/Becton Dick-
inson). Online data acquisition and further analysis were performed using
Summit 4.0 software. Lactate production rate was determined spectrophoto-
metrically, as previously described in Garedew and Moncada (2008).
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Figure 7. Effect of siRNA-Mediated
Silencing of Opa1 and Tfam on Respiration
and Mitochondrial Morphology
(A–C) Silencing ofOpa1 or Tfamwas carried out for
72 hr either under proliferating (10% FCS) or
serum-starved (0.1% FCS) conditions. Basal
respiration (A, left panel) and FCCP-uncoupled
maximum respiration (A, right panel) were
measured, and mitochondrial morphology (B) was
evaluated after staining with 100 nM MitoTracker
Green FM and Hoechst 33342 of proliferating,
serum-starved and 24 hr refed MEFs. (C) shows
the proportion of cells with different mitochondrial
morphology, assessed as in Figure 3B. (A) shows
mean ± SD (n=3) and (B) shows representative
confocal images. Areas of increasedmagnification
are indicated by the white boxes in (B). Control,
nontransfected cells. *p % 0.05 versus control
and scrambled siRNA-transfected cells (ANOVA,
Tukey’s post hoc test). See also Figure S5.
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EDEvaluation of Mitochondrial Mass
and Morphology by Flow Cytometry
and Confocal Microscopy
For flow cytometric determination of mitochondrial mass, the cationic dye
MitoTracker Green FM was added to the attached cell layer (MEFs) or cell
suspension (T cells) at 100 nM final concentration, and cells were incubated
for 30 min at 37C. Free fluorochrome was removed from the mitochondrial
matrix by completely collapsing the mitochondrial membrane potentialCell Metabolism 15, 466–(DJm) with 20 mM FCCP. After washing the
excess dye with DPBS, cells were spun down
and resuspended in DPBS supplemented with
5 mM glucose. Then, the fluorescence of Mito-
Tracker Green FM bound to the matrix com-
ponents was analyzed immediately by flow
cytometry by acquiring 104 events, and median
fluorescence values were used to compare
groups.
Detailed mitochondrial morphology analysis
was performed by usingMEFs seeded and treated
in Eight Chambered Coverglass (Lab-Tek; Nunc)
microscopic imaging chambers. MEFs were
stained for 30 min at 37C with 100 nM Mito-
Tracker Green FM and 2 mg/ml Hoechst 33342
for nuclear staining. For the time course experi-
ments of mitochondrial morphology after serum
refeeding, staining with MitoTracker Green FM
and Hoechst 33342 was carried out in the last
30 min of each time point. For imaging, cells
were rinsed with DPBS, 200 ml of phenol red-free
DMEM supplemented with 25 mM HEPES buffer
was added into each chamber, and imaging was
performed immediately. Images of several fields
were taken for each treatment group, 200 cells
were randomly selected, and their mitochondrial
morphology was visually scored as tubular, inter-
mediate, or fragmented.
Although it was not possible to visualize detailed
mitochondrial morphology in T cells because of
their small size, mitochondrial biogenesis could
be evaluated by confocal microscopy because of
the dramatic increase in mitochondrial mass
following activation. T cell suspensions were
stained as described for MEFs and resuspended
in phenol red-free RPMI-1640 supplemented with
T25 mMHEPES before seeding in microscopic imaging chambers coated over-
night with 300 mg/ml poly-D-lysine. T cells were allowed to attach for 30 min
before imaging.
Confocal microscopic images were taken with a Scanning Disk UltraVIEW
ERS Live Cell Confocal Microscope (PerkinElmer) using a 1003 oil immersion
objective. Cells were kept at 37Cduring the entire imaging period. Online data
acquisition and further fluorescence analysis were carried out using Volocity
5.5 software.479, April 4, 2012 ª2012 Elsevier Inc. 477
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Cells were lysed with a modified Radio-ImmunoPrecipitation Assay buffer
(without sodium deoxycholate and SDS to prevent protein denaturation).
Cell homogenates were spun down at 13,000 rpm to remove debris, and CS
enzymatic activity was determined spectrophotometrically by measuring the
rate of liberation of Coenzyme A (CoASH) from acetyl-CoA and oxaloacetate,
which is coupled to the irreversible cleavage of 5,50dithiobis(2-nitrobenzoic)
acid (DTNB) to CoAS-S-TNB and 2-nitro-5-thiobenzoic acid (TNB) (Berg-
meyer, 1974). The rate of formation of TNB at 37C was measured by reading
the change in absorbance at 412 nm in a kinetic mode, every 20 s for a total of
10 min, using SpectraMax M2e Microplate reader and Softmax Pro software
(Molecular Devices). The reaction mixture contained 1 mM DTNB, 0.313 mM
acetyl CoA, and 0.5mMoxaloacetate in Tris-HCl buffer (pH 8.1). CS enzymatic
activity was normalized to cell number or total protein of the homogenate, as
indicated.
Determination of Cellular ATP
Cellular ATP content was determined in cell lysates using a luciferase-based
ATP assay kit ATPlite (PerkinElmer), according to the recommended proce-
dure. For experiments that involve replacement of medium glucose with galac-
tose—a carbohydrate whose utilization requires functional mitochondria—the
old medium was aspirated, and the cell layer was rinsed with PBS. Cells were
then fed with medium containing 10 mM galactose instead of glucose and
incubated for 2 hr before lysis for ATP determination. Normalization was per-
formed with the protein concentration in the cell lysate.
Respirometry
For the respirometric analysis of mitochondrial function, MEFs were resus-
pended at 2 3 106 cells/ml and T cells at 5 3 106 cells/ml. Oxygen uptake
was measured using an airtight glass chamber respirometer (Rank Brothers,
Cambridge) at 37C as previously described for intact cells (Garedew and
Moncada, 2008).
Immunoprecipitation
MEFs starved of serum for 72 hr were incubated with 10 mMproteasome inhib-
itor MG132 for 2 hr. Cells were lysed, as described in the previous section.
Protein G-Dynabeads (Invitrogen) were prepared following the manufacturer’s
recommendations by taking 50 ml bead suspension and conjugating them to
10 mg antibodies against OPA1, or TFAM, or MFN1 (all raised in rabbit) by incu-
bation on a rotating wheel overnight at 4C. Proteins were immunoprecipitated
by incubating 50 mg cell lysate with the bead-antibody complex on a rotating
wheel at room temperature for 2 hr. Beads were processed according to
manufacturer’s recommendations, and immunoprecipitated proteins eluted
by heating at 90C for 10 min in 25 ml Laemmli buffer were loaded into SDS-
PAGE. Ubiquitinated proteins were detected using mouse monoclonal anti-
ubiquitin antibody (NEB).
Cloning and Site-Directed Mutagenesis
Mouse Opa1 (mOpa1)-coding sequence was subcloned from pBSSK-mOpa1
(a kind gift from Y. Kubo, NIPS, Japan) by KpnI and NotI digestions into
pcDNA3.0 (Invitrogen). Mouse Tfam (mTfam)-coding sequence was subcl-
oned from pGEM-4z-Tfam (a kind gift from NG Larsson, MPG, Germany) by
EcoRI and XbaI digestion into pME18S (a kind gift of A. Nott, UCL, UK).
Mammalian expression vector for mouse Cdh1 (pEYFP-mFzr1) was a kind
gift from S. Geley (IMU, Austria). pCDNA3.1(-)-Mfn1-Myc/His was purchased
from Addgene. The KEN and D boxes of OPA1, TFAM, and MFN1 were
mutated by site-directed mutagenesis using the QuikChange Lightning Site-
Directed Mutagenesis Kit (Stratagene) according to the manufacturer’s
instructions. Primer sequences are listed in Table S3.
Gene Silencing with siRNA
Commercially available siRNAs against mFzr1 (mCdh1), mTfam, mOpa1
(ON-TARGETplus SMARTpool), and a nontargeting control siRNAs were all
purchased from Thermo Scientific-Dharmacon. For the silencing of Opa1 or
Tfam in serum-starved cells, MEFs seeded at 0.1 3 106 cells/well in 6-well
plates were grown for 24 hr followed by 12 hr serum starvation. Cells were
then transfected for 12 hr with 50 nM siRNA in serum-starvation medium.
Transfection medium was replaced with serum-starvation medium alone,
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Cells were then harvested or transfected again for 12 hr with 50 nM siRNA in
10% FCS medium and then incubated for further 12 hr in 10% FCS medium
without siRNA.
For the silencing of Opa1, Tfam, and Cdh1 in proliferating conditions, MEFs
seeded at 0.5 3 105 cells/well in 6-well plates were grown for 24 hr and
transfected for 12 hr with 50 nM siRNAs in 10% FCS medium. The medium
was then changed, and samples were collected after 48 hr.
Detailed experimental procedures on RNA extraction, cDNA synthesis, and
quantitative real-time PCR, DNA extraction and quantitative PCR, protein elec-
trophoresis and western blotting are available in Supplemental Experimental
Procedures.
Statistical Analysis
Data are summarized as mean or mean ± SD. Statistical significance was
assessed by performing paired sample t test or analysis of variance (ANOVA)
followed by Tukey’s post hoc test for multiple comparisons, by using Origin 8.5
Pro Software.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures, four tables, and Supplemental
Experimental Procedures and can be found with this article online at
doi:10.1016/j.cmet.2012.03.003.
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